|
|
The Biomedical & Life Sciences Collection
New
Releases for December
|
|
|
|
|
The complement system
in innate and adaptive immunity: normal functioning of the complement
system
Prof.
Steven Sacks
King's College London, UK
|
|
|
|
|
|
Lewy body dementia
Prof.
John-Paul Taylor
Newcastle University, UK
|
|
|
|
|
|
Hypersensitivity
diseases: type II-IV hypersensitivity
Prof.
Sara Marshall
Wellcome Trust, UK
|
|
|
|
|
|
The basic epidemiology
of tuberculosis (TB)
Dr.
David Dowdy
Johns Hopkins Bloomberg School of Public Health, USA
|
|
|
|
|
|
The complement system
in innate and adaptive immunity: diseases mediated by the complement
system
Prof.
Steven Sacks
King's College London, UK
|
|
|
|
|
|
The genetics of
stuttering
Dr.
Dennis Drayna
National Institute on Deafness and Other Communication Disorders, USA
|
|
|
|
|
|
Surveillance,
prevention, and control of vector-borne diseases
Prof.
Jonathan Day
University of Florida, USA
|
|
|
|
|
|
G proteins and the
biology of depression and antidepressants
Prof.
Mark M. Rasenick
University of Illinois, USA
|
|
|
|
|
|
The pathogenesis of
tuberculosis
Dr.
William R. Bishai
Johns Hopkins University School of Medicine, USA
|
|
|
|
|
|
Roles of AMPK in energy
homeostasis and nutrient sensing
Prof.
Grahame Hardie
University of Dundee, UK
|
|
|
|
|
|
Preclinical translation
of mesenchymal stem cell therapies
Dr.
Peter Childs
University of Strathclyde, UK
|
|
|
|
|
|
The End TB Strategy
towards TB elimination
Dr.
Mario Raviglione
University of Milan, Italy
|
|
|
|
|
|
Development and
regulation of cellular and gene therapy products: FDA perspective
Dr.
Larissa Lapteva
Center for Biologics Evaluation and Research, FDA, USA
|
|
|
|
|
|
Multidrug resistant
tuberculosis (MDR-TB): an update
Dr.
Simon Tiberi
Queen Mary University of London, UK
|
|
|
|
|
|
Challenging patents:
third party observations
Dr.
Jonathan D.M. Atkinson
Partner HGF Limited and Director, Atkinson IP Consulting Limited, UK
|
|
|
|
|
|
Challenging patents:
EPO oppositions and appeals
Dr.
Jonathan D.M. Atkinson
Partner HGF Limited and Director, Atkinson IP Consulting Limited, UK
|
|
|
|
|
Featured
talks from previous releases
|
|
|
|
|
|
For more specially commissioned lectures:
|
